A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone
Completed
Novo Nordisk A/S
Phase 2
2009-08-01
This trial is conducted in Europe. The aim of this clinical trial is to investigate the
safety, tolerability, pharmacokinetics (the determination of the concentration of the
administered medication in blood over time) and pharmacodynamics (the determination of the
effect over time and the duration of action) of a long-acting growth hormone (NNC126-0083) in
growth hormone deficient children.
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
Completed
Novo Nordisk A/S
2011-04-01
This study is conducted in Europe. The purpose of this study is to assess the impact on daily
life for children new to using a growth hormone injection device.
A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency
Completed
Novo Nordisk A/S
Phase 1
2012-10-12
This trial is conducted in Europe. The aim of the trial is to investigate the safety,
tolerability, availability and distribution in the body of once-weekly long-acting growth
hormone (NNC0195-0092, somapacitan) compared to once daily Norditropin NordiFlex® in adults
with growth hormone deficiency (GHD).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.